Darou Pakhsh

Darou Pakhsh Holding Company
Public
Traded as TSE: DARO1
ISIN: IRO1DARO0008
Industry Pharmaceuticals
Founded 1956 (as Darou Pakhsh)
1997 (as Darou Pakhsh Holding)
Headquarters Tehran, Iran
Owner TPICO (74.5%)[1]
Website www.dpholding.com

Darou Pakhsh Holding Company (Persian: شرکت داروپخش‎‎) is a major pharmaceutical company in Iran. The company is majority-owned by the Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm.[2] The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004.[2] Darou Pakhsh is listed on the Tehran Stock Exchange.

History

Initially, the plant had been designed to produce 20 dosage forms. During over 40 years of activity in pharmaceutical industry, the company has been employing many qualified pharmacists, expert chemists, & skilled technicians. Also, modern machinery installation, equipping the laboratory with new analytical instruments, taking advantage of facilities along with decades of gaining scientific knowledge has brought the company up-to-date in all its sections which conform to the latest standards

See also

References

  1. ↑ "Daroupakhsh ( DARO1 ) info". tsetmc.com. Retrieved 2012-05-26.
  2. 1 2 IRAN: Healthcare and Pharmaceuticals Forecast, Economist Intelligence Unit, August 18, 2008

External links

This article is issued from Wikipedia - version of the Thursday, April 14, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.